Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Babaloo, Zohreh  [Clear All Filters]
Journal Article
Firouzi-Amandi A, Dadashpour M, Nouri M, Zarghami N, Serati-Nouri H, Jafari-Gharabaghlou D, Karzar BHazhir, Mellatyar H, Aghebati-Maleki L, Babaloo Z, et al. Chrysin-nanoencapsulated PLGA-PEG for macrophage repolarization: Possible application in tissue regeneration. Biomed Pharmacother. 2018;105:773-780.
Ahmadi M, Yousefi M, Abbaspour-Aghdam S, Dolati S, Aghebati-Maleki L, Eghbal-Fard S, Khabbazi A, Rostamzadeh D, Alipour S, Shabani M, et al. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease. J Cell Physiol. 2018.
Ghorbani F, Fathi F, Aghebati-Maleki L, Abolhasan R, Rikhtegar R, Dolatabadi JEzzati Naz, Babaloo Z, Khalilzadeh B, Ebrahimi-Warkiani M, Sharifzadeh Z, et al. Kinetic and thermodynamic study of c-Met interaction with single chain fragment variable (scFv) antibodies using phage based surface plasmon resonance. Eur J Pharm Sci. 2020:105362.
Rostamzadeh D, Yousefi M, Haghshenas MReza, Ahmadi M, Dolati S, Babaloo Z. mTOR Signaling pathway as a master regulator of memory CD8 T-cells, Th17, and NK cells development and their functional properties. J Cell Physiol. 2019.
Ahmadi M, Abdolmohamadi-Vahid S, Ghaebi M, Dolati S, Abbaspour-Aghdam S, Danaii S, Berjis K, Madadi-Javid R, Nouri Z, Siahmansouri H, et al. Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial. Int Immunopharmacol. 2019;74:105730.